Mitochondrial biology in Alzheimer's disease pathogenesis: REVIEW

Journal of Neurochemistry

Volumn 114, Issue 4, 2010, Pages 933-945

  Galindo, María F ^a   Ikuta, Ichiro ^b   Zhu, Xiongwei ^c   Casadesus, Gemma ^d   Jordán, Joaquín ^e  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

apoptosis; Bax; beta amyloid; mitochondrial membrane permeabilization; mitochondrial membrane potential; mitochondrial permeability transition pore; reactive oxygen species

Indexed keywords

AMYLOID BETA PROTEIN; HEAT SHOCK PROTEIN; POLYUNSATURATED FATTY ACID; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; TAU PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; CELL DISRUPTION; CELL PROTECTION; CYTOLOGY; CYTOTOXICITY; DRUG TARGETING; ELECTRIC POTENTIAL; GENE EXPRESSION; GLIOSIS; HUMAN; INTRACELLULAR SIGNALING; MEMBRANE BINDING; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SENILE PLAQUE; UPREGULATION; ANIMAL; METABOLISM; MITOCHONDRIAL DISEASES; PATHOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES;

EID: 77954755957     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06814.x     Document Type: Review

References (134)

1. Abramov A. Y., Canevari L. Duchen M. R. (2004) Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J. Neurosci. 24, 565 575.
2. Akao Y., Otsuki Y., Kataoka S., Ito Y. Tsujimoto Y. (1994) Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res. 54, 2468 2471.
3. Akao Y., Maruyama W., Shimizu S., Yi H., Nakagawa Y., Shamoto-Nagai M., Youdim M. B., Tsujimoto Y. Naoi M. (2002) Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan. J. Neurochem. 82, 913 923.
4. Alexander G. E., Chen K., Pietrini P., Rapoport S. I. Reiman E. M. (2002) Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am. J. Psychiatry 159, 738 745.
5. Almeida A., Almeida J., Bolaños J. P. Moncada S. (2001) Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection. Proc. Natl. Acad. Sci. USA 98, 15294 15299.
6. Anandatheerthavarada H. K., Biswas G., Robin M. A. Avadhani N. G. (2003) Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161, 41 54.
7. Andreyev A. Y., Kushnareva Y. E. Starkov A. A. (2005) Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc) 70, 200 214.
8. Ankarcrona M., Dypbukt J. M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S. A. Nicotera P. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961 973.
9. Arispe N., Diaz J. C. Simakova O. (2007) Abeta ion channels. Prospects for treating Alzheimer's disease with Abeta channel blockers. Biochim. Biophys. Acta 1768, 1952 1965.
10. Balaban R. S., Nemoto S. Finkel T. (2005) Mitochondria, oxidants, and aging. Cell 120, 483 495.
11. Beal M. F. (2003) Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann. N Y Acad. Sci. 991, 120 131.
12. Beltrán B., Mathur A., Duchen M. R., Erusalimsky J. D. Moncada S. (2000) The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death. Proc. Natl. Acad. Sci. USA 97, 14602 14607.
13. Benard G., Bellance N., James D., Parrone P., Fernandez H., Letellier T. Rossignol R. (2007) Mitochondrial bioenergetics and structural network organization. J. Cell Sci. 120, 838 848.
14. Bielarczyk H., Gul S., Ronowska A., Bizon-Zygmanska D., Pawelczyk T. Szutowicz A. (2006) RS-alpha-lipoic acid protects cholinergic cells against sodium nitroprusside and amyloid-beta neurotoxicity through restoration of acetyl-CoA level. J. Neurochem. 98, 1242 1251.
15. Blass J. P. (2000) The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome. Ann. N Y Acad. Sci. 924, 170 183.
16. Brown G. C. Borutaite V. (2002) Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic. Biol. Med. 33, 1440 1450.
17. Butterworth R. F. Besnard A. M. (1990) Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease. Metab. Brain Dis. 5, 179 184.
18. Casley C. S., Canevari L., Land J. M., Clark J. B. Sharpe M. A. (2002) Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80, 91 100.
19. Caspersen C., Wang N., Yao J. et al. (2005) Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 19, 2040 2041.
20. Cente M., Filipcik P., Pevalova M. Novak M. (2006) Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy. Eur. J. Neurosci. 24, 1085 1090.
21. Chan D. C. (2006) Mitochondrial fusion and fission in mammals. Annu. Rev. Cell Dev. Biol. 22, 79 99.
22. Choi Y., Kim H. S., Shin K. Y. et al. (2007) Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacology 32, 2393 2404.
23. Crouch P. J., Blake R., Duce J. A. et al. (2005) Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J. Neurosci. 25, 672 679.
24. Devi L., Prabhu B. M., Galati D. F., Avadhani N. G. Anandatheerthavarada H. K. (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci. 26, 9057 9068.
25. Diaz J. C., Linnehan J., Pollard H. Arispe N. (2006) Histidines 13 and 14 in the Abeta sequence are targets for inhibition of Alzheimer's disease Abeta ion channel and cytotoxicity. Biol. Res. 39, 447 460.
26. Du H., Guo L., Fang F. et al. (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat. Med. 14, 1097 1105.
27. Duchen M. R. (2000) Mitochondria and calcium: from cell signalling to cell death. J. Physiol. 529 (Pt 1 57 68.
28. Dugan L. L., Sensi S. L., Canzoniero L. M., Handran S. D., Rothman S. M., Lin T. S., Goldberg M. P. Choi D. W. (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15, 6377 6388.
29. Eckert A., Keil U., Kressmann S., Schindowski K., Leutner S., Leutz S. Muller W. E. (2003) Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry 36 (Suppl 1 S15 S23.
30. Eckert A., Hauptmann S., Scherping I., Rhein V., Muller-Spahn F., Gotz J. Muller W. E. (2008) Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice. Neurodegener. Dis. 5, 157 159.
31. Engelhart M. J., Geerlings M. I., Meijer J. et al. (2004) Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch. Neurol. 61, 668 672.
32. Fernandez-Gomez F. J., Galindo M. F., Gomez-Lazaro M., Gonzalez-Garcia C., Cena V., Aguirre N. Jordan J. (2005) Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions. Neuroscience 133, 959 967.
33. Frey T. G. Mannella C. A. (2000) The internal structure of mitochondria. Trends Biochem. Sci. 25, 319 324.
34. Fukuyama H., Ogawa M., Yamauchi H., Yamaguchi S., Kimura J., Yonekura Y. Konishi J. (1994) Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J. Nucl. Med. 35, 1 6.
35. Galindo M. F., Jordan J., Gonzalez-Garcia C. Cena V. (2003) Reactive oxygen species induce swelling and cytochrome c release but not transmembrane depolarization in isolated rat brain mitochondria. Br. J. Pharmacol. 139, 797 804.
36. Garcia-Martinez E. M., Sanz-Blasco S., Karachitos A. et al. (2010) Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells. Biochem. Pharmacol. 79, 239 250.
37. Garcia-Saez A. J., Coraiola M., Dalla Serra M., Mingarro I., Menestrina G. Salgado J. (2005) Peptides derived from apoptotic Bax and Bid reproduce the poration activity of the parent full-length proteins. Biophys. J. 88, 3976 3990.
38. Gervais F. G., Xu D., Robertson G. S. et al. (1999) Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 97, 395 406.
39. Gibson G. E., Zhang H., Sheu K. F., Bogdanovich N., Lindsay J. G., Lannfelt L., Vestling M. Cowburn R. F. (1998) Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670671 mutation. Ann. Neurol. 44, 676 681.
40. Gomez-Lazaro M., Galindo M. F., Melero-Fernandez de Mera R. M., Fernandez-Gomez F. J., Concannon C. G., Segura M. F., Comella J. X., Prehn J. H. Jordan J. (2007) Reactive oxygen species and p38 mitogen-activated protein kinase activate Bax to induce mitochondrial cytochrome c release and apoptosis in response to malonate. Mol. Pharmacol. 71, 736 743.
41. Gray C. W. Patel A. J. (1995) Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction. Brain Res. 691, 169 179.
42. Gu Q. B., Zhao J. X., Fei J. Schwarz W. (2004) Modulation of Na(+),K(+) pumping and neurotransmitter uptake by beta-amyloid. Neuroscience 126, 61 67.
43. Gunter T. E., Buntinas L., Sparagna G., Eliseev R. Gunter K. (2000) Mitochondrial calcium transport: mechanisms and functions. Cell Calcium 28, 285 296.
44. Halestrap A. P., Clarke S. J. Javadov S. A. (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc. Res. 61, 372 385.
45. Hansson C. A., Frykman S., Farmery M. R. et al. (2004) Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J. Biol. Chem. 279, 51654 51660.
46. Hauptmann S., Scherping I., Drose S., Brandt U., Schulz K. L., Jendrach M., Leuner K., Eckert A. Muller W. E. (2009) Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol. Aging 30, 1574 1586.
47. He X. Y., Wen G. Y., Merz G., Lin D., Yang Y. Z., Mehta P., Schulz H. Yang S. Y. (2002) Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model. Brain Res. Mol. Brain Res. 99, 46 53.
48. Hirabara S. M., Silveira L. R., Alberici L. C. et al. (2006) Acute effect of fatty acids on metabolism and mitochondrial coupling in skeletal muscle. Biochim. Biophys. Acta 1757, 57 66.
49. Hirai K., Hayako H., Kato K. Miyamoto M. (1998) Idebenone protects hippocampal neurons against amyloid beta-peptide-induced neurotoxicity in rat primary cultures. Naunyn Schmiedebergs Arch. Pharmacol. 358, 582 585.
50. Hirai K., Aliev G., Nunomura A. et al. (2001) Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21, 3017 3023.
51. Hoglinger G. U., Lannuzel A., Khondiker M. E. et al. (2005) The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J. Neurochem. 95, 930 939.
52. Hollenbeck P. J. (2005) Mitochondria and neurotransmission: evacuating the synapse. Neuron 47, 331 333.
53. Imam S. Z., Karahalil B., Hogue B. A., Souza-Pinto N. C. Bohr V. A. (2006) Mitochondrial and nuclear DNA-repair capacity of various brain regions in mouse is altered in an age-dependent manner. Neurobiol. Aging 27, 1129 1136.
54. Johnson N., Khan A., Virji S., Ward J. M. Crompton M. (1999) Import and processing of heart mitochondrial cyclophilin D. Eur. J. Biochem. 263, 353 359.
55. Jordan J., Galindo M. F. Miller R. J. (1997) Role of calpain- and interleukin-1 beta converting enzyme-like proteases in the beta-amyloid-induced death of rat hippocampal neurons in culture. J. Neurochem. 68, 1612 1621.
56. Jordan J., Cena V. Prehn J. H. (2003) Mitochondrial control of neuron death and its role in neurodegenerative disorders. J. Physiol. Biochem. 59, 129 141.
57. Jordan J., Fernandez-Gomez F. J., Ramos M., Ikuta I., Aguirre N. Galindo M. F. (2007) Minocycline and cytoprotection: shedding new light on a shadowy controversy. Curr. Drug Deliv. 4, 225 231.
58. Kann O. Kovacs R. (2007) Mitochondria and neuronal activity. Am. J. Physiol. Cell Physiol. 292, C641 C657.
59. Keil U., Bonert A., Marques C. A., Strosznajder J. B., Muller-Spahn F., Muller W. E. Eckert A. (2004) Elevated nitric oxide production mediates beta-amyloid-induced mitochondria failure. Pol. J. Pharmacol. 56, 631 634.
60. Keller J. N., Mark R. J., Bruce A. J., Blanc E., Rothstein J. D., Uchida K., Waeg G. Mattson M. P. (1997a) 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80, 685 696.
61. Keller J. N., Pang Z., Geddes J. W., Begley J. G., Germeyer A., Waeg G. Mattson M. P. (1997b) Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69, 273 284.
62. Kennedy B. P., Ziegler M. G., Alford M., Hansen L. A., Thal L. J. Masliah E. (2003) Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease. J. Neural. Transm. 110, 789 801.
63. Kim H. S., Lee J. H., Lee J. P. et al. (2002) Amyloid beta peptide induces cytochrome C release from isolated mitochondria. Neuroreport 13, 1989 1993.
64. Kish S. J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L. J., Wilson J. M., DiStefano L. M. Nobrega J. N. (1992) Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59, 776 779.
65. Knott A. B. Bossy-Wetzel E. (2008) Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration. Ann. N Y Acad. Sci. 1147, 283 292.
66. Krajewski S., Tanaka S., Takayama S., Schibler M. J., Fenton W. Reed J. C. (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53, 4701 4714.
67. Kruman I. I. Mattson M. P. (1999) Pivotal role of mitochondrial calcium uptake in neural cell apoptosis an0064 necrosis. J. Neurochem. 72, 529 540.
68. Lemasters J. J., Nieminen A. L., Qian T. et al. (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366, 177 196. (Pubitemid 28467031)
69. Levites Y., Weinreb O., Maor G., Youdim M. B. Mandel S. (2001) Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 78, 1073 1082.
70. Liu X., Kim C. N., Yang J., Jemmerson R. Wang X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147 157.
71. Louneva N., Cohen J. W., Han L. Y., Talbot K., Wilson R. S., Bennett D. A., Trojanowski J. Q. Arnold S. E. (2008) Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease. Am. J. Pathol. 173, 1488 1495.
72. Lustbader J. W., Cirilli M., Lin C. et al. (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304, 448 452.
73. MacGibbon G. A., Lawlor P. A., Sirimanne E. S. et al. (1997) Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res. 750, 223 234.
74. Maczurek A., Hager K., Kenklies M., Sharman M., Martins R., Engel J., Carlson D. A. Munch G. (2008) Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv. Drug Deliv. Rev. 60, 1463 1470.
75. Manczak M., Anekonda T. S., Henson E., Park B. S., Quinn J. Reddy P. H. (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15, 1437 1449.
76. Mastrogiacoma F., Lindsay J. G., Bettendorff L., Rice J. Kish S. J. (1996) Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. Ann. Neurol. 39, 592 598.
77. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I. Rydel R. E. (1992) beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376 389.
78. McAllister J., Ghosh S., Berry D., Park M., Sadeghi S., Wang K. X., Parker W. D. Swerdlow R. H. (2008) Effects of memantine on mitochondrial function. Biochem. Pharmacol. 75, 956 964.
79. Miller 3rd. E. R., Pastor-Barriuso R., Dalal D., Riemersma R. A., Appel L. J. Guallar E. (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142, 37 46.
80. Minoshima S., Giordani B., Berent S., Frey K. A., Foster N. L. Kuhl D. E. (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 42, 85 94.
81. Moreira P. I., Santos M. S., Moreno A. Oliveira C. (2001) Amyloid beta-peptide promotes permeability transition pore in brain mitochondria. Biosci. Rep. 21, 789 800.
82. Moreira P. I., Santos M. S., Moreno A., Rego A. C. Oliveira C. (2002) Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J. Neurosci. Res. 69, 257 267.
83. Moreira P. I., Harris P. L., Zhu X., Santos M. S., Oliveira C. R., Smith M. A. Perry G. (2007) Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J. Alzheimers Dis. 12, 195 206.
84. Paola D., Domenicotti C., Nitti M. et al. (2000) Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem. Biophys. Res. Commun. 268, 642 646.
85. Pappolla M. A., Chyan Y. J., Omar R. A., Hsiao K., Perry G., Smith M. A. Bozner P. (1998) Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am. J. Pathol. 152, 871 877.
86. Patterson S. D., Spahr C. S., Daugas E., Susin S. A., Irinopoulou T., Koehler C. Kroemer G. (2000) Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition. Cell Death Differ. 7, 137 144.
87. Perry G., Nunomura A., Hirai K., Takeda A., Aliev G. Smith M. A. (2000) Oxidative damage in Alzheimer's disease: the metabolic dimension. Int. J. Dev. Neurosci. 18, 417 421. (Pubitemid 30243071)
88. Perry G., Cash A. D. Smith M. A. (2002) Alzheimer disease and oxidative stress. J. Biomed. Biotechnol. 2, 120 123.
89. Petit P. X., Goubern M., Diolez P., Susin S. A., Zamzami N. Kroemer G. (1998) Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: the impact of irreversible permeability transition. FEBS Lett. 426, 111 116.
90. Poncet D., Larochette N., Pauleau A. L. et al. (2004) An anti-apoptotic viral protein that recruits Bax to mitochondria. J. Biol. Chem. 279, 22605 22614.
91. Pratico D., Uryu K., Leight S., Trojanoswki J. Q. Lee V. M. (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21, 4183 4187.
92. Prehn J. H., Bindokas V. P., Jordan J. et al. (1996) Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol. Pharmacol. 49, 319 328.
93. Quinn J. F., Bussiere J. R., Hammond R. S., Montine T. J., Henson E., Jones R. E. Stackman Jr. R. W. (2007) Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol. Aging 28, 213 225.
94. Radi R., Cassina A., Hodara R., Quijano C. Castro L. (2002) Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med. 33, 1451 1464.
95. Reddy P. H. (2006a) Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J. Neurochem. 96, 1 13.
96. Reddy P. H. (2006b) Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics. J. Biomed. Biotechnol. 2006, 31372.
97. Rohn T. T., Head E., Su J. H., Anderson A. J., Bahr B. A., Cotman C. W. Cribbs D. H. (2001) Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am. J. Pathol. 158, 189 198.
98. Rohn T. T., Rissman R. A., Davis M. C., Kim Y. E., Cotman C. W. Head E. (2002) Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol. Dis. 11, 341 354. (Pubitemid 36135697)
99. Rui Y., Tiwari P., Xie Z. Zheng J. Q. (2006) Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J. Neurosci. 26, 10480 10487.
100. 2+-dependent mechanisms of presynaptic control at central synapses. Neuroscientist 12, 317 326.
101. Sajan F. D., Martiniuk F., Marcus D. L., Frey 2nd. W. H., Hite R., Bordayo E. Z. Freedman M. L. (2007) Apoptotic gene expression in Alzheimer's disease hippocampal tissue. Am. J. Alzheimers Dis. Other Demen. 22, 319 328.
102. Sakurai K., Stoyanovsky D. A., Fujimoto Y. Cederbaum A. I. (2000) Mitochondrial permeability transition induced by 1-hydroxyethyl radical. Free Radic. Biol. Med. 28, 273 280.
103. Sarti P., Arese M. Giuffre A. (2003) The molecular mechanisms by which nitric oxide controls mitochondrial complex IV. Ital. J. Biochem. 52, 37 42.
104. Saura J., Luque J. M., Cesura A. M., Da Prada M., Chan-Palay V., Huber G., Loffler J. Richards J. G. (1994) Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62, 15 30.
105. Shevtzova E. F., Kireeva E. G. Bachurin S. O. (2001) Effect of beta-amyloid peptide fragment 25-35 on nonselective permeability of mitochondria. Bull. Exp. Biol. Med. 132, 1173 1176.
106. Smith M. A., Perry G., Richey P. L., Sayre L. M., Anderson V. E., Beal M. F. Kowall N. (1996) Oxidative damage in Alzheimer's. Nature 382, 120 121.
107. Sorbi S., Bird E. D. Blass J. P. (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann. Neurol. 13, 72 78.
108. Starkov A. A., Fiskum G., Chinopoulos C., Lorenzo B. J., Browne S. E., Patel M. S. Beal M. F. (2004) Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 24, 7779 7788.
109. Stokin G. B., Lillo C., Falzone T. L. et al. (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307, 1282 1288.
110. Swerdlow R. H. (2007) Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem. Antioxid. Redox Signal. 9, 1591 1603.
111. Takuma K., Fang F., Zhang W. et al. (2009) RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc. Natl Acad. Sci. USA 106, 20021 20026.
112. Tamagno E., Guglielmotto M., Aragno M. et al. (2008) Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J. Neurochem. 104, 683 695.
113. Thal L. J., Kantarci K., Reiman E. M. et al. (2006) The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 20, 6 15.
114. Turrens J. F. (2003) Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335 344.
115. Veereshwarayya V., Kumar P., Rosen K. M., Mestril R. Querfurth H. W. (2006) Differential effects of mitochondrial heat shock protein 60 and related molecular chaperones to prevent intracellular beta-amyloid-induced inhibition of complex IV and limit apoptosis. J. Biol. Chem. 281, 29468 29478.
116. Vina J., Lloret A., Valles S. L., Borras C., Badia M. C., Pallardo F. V., Sastre J. Alonso M. D. (2007) Effect of gender on mitochondrial toxicity of Alzheimer's Abeta peptide. Antioxid. Redox Signal. 9, 1677 1690.
117. Wallace D. C. (2001) A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found. Symp. 235, 247 263 discussion 263-266.
118. Wang X., Su B., Fujioka H. Zhu X. (2008a) Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am. J. Pathol. 173, 470 482.
119. Wang X., Su B., Siedlak S. L., Moreira P. I., Fujioka H., Wang Y., Casadesus G. Zhu X. (2008b) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fissionfusion proteins. Proc. Natl Acad. Sci. USA 105, 19318 19323.
120. Wang X., Su B., Lee H. G., Li X., Perry G., Smith M. A. Zhu X. (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci. 29, 9090 9103.
121. Whitehouse P. J., Price D. L., Clark A. W., Coyle J. T. DeLong M. R. (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10, 122 126.
122. Winblad B. Poritis N. (1999) Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int. J. Geriatr. Psychiatry 14, 135 146.
123. Wolter K. G., Hsu Y. T., Smith C. L., Nechushtan A., Xi X. G. Youle R. J. (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281 1292.
124. Xiong K., Cai H., Luo X. G., Struble R. G., Clough R. W. Yan X. X. (2007) Mitochondrial respiratory inhibition and oxidative stress elevate beta-secretase (BACE1) proteins and activity in vivo in the rat retina. Exp. Brain Res. 181, 435 446.
125. Xu J., Yu S., Sun A. Y. Sun G. Y. (2003) Oxidant-mediated AA release from astrocytes involves cPLA(2) and iPLA(2). Free Radic. Biol. Med. 34, 1531 1543.
126. Yan S. D., Fu J., Soto C. et al. (1997) An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389, 689 695.
127. Yan S. D., Shi Y., Zhu A. et al. (1999) Role of ERABL-3-hydroxyacyl- coenzyme A dehydrogenase type II activity in Abeta-induced cytotoxicity. J. Biol. Chem. 274, 2145 2156.
128. Yang F., Sun X., Beech W., Teter B., Wu S., Sigel J., Vinters H. V., Frautschy S. A. Cole G. M. (1998) Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am. J. Pathol. 152, 379 389.
129. Yogev-Falach M., Bar-Am O., Amit T., Weinreb O. Youdim M. B. (2006) A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing. FASEB J. 20, 2177 2179.
130. Youdim M. B., Bar Am O., Yogev-Falach M., Weinreb O., Maruyama W., Naoi M. Amit T. (2005) Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition. J. Neurosci. Res. 79, 172 179.
131. Zandi P. P., Anthony J. C., Khachaturian A. S., Stone S. V., Gustafson D., Tschanz J. T., Norton M. C., Welsh-Bohmer K. A. Breitner J. C. (2004) Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch. Neurol. 61, 82 88.
132. Zhang D., Zhang Y., Liu G. Zhang J. (2006) Dactylorhin B reduces toxic effects of beta-amyloid fragment (25-35) on neuron cells and isolated rat brain mitochondria. Naunyn Schmiedebergs Arch. Pharmacol. 374, 117 125.
133. Zhu X., Perry G., Moreira P. I., Aliev G., Cash A. D., Hirai K. Smith M. A. (2006) Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. J. Alzheimers Dis. 9, 147 153. (Pubitemid 44078642)
134. Zhu X., Su B., Wang X., Smith M. A. Perry G. (2007) Causes of oxidative stress in Alzheimer disease. Cell. Mol. Life Sci. 64, 2202 2210. (Pubitemid 47347959)